• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Michele McCourt on Directing Patients to Financial Medication Assistance

Video

Michele McCourt, senior director of the CancerCare Co-Payment Assistance Foundation, recognizes the financial hardships of cancer patients when paying for medications.

Michele McCourt, senior director of the CancerCare Co-Payment Assistance Foundation, recognizes the financial hardships of cancer patients when paying for medications.

Transcript

Are you hearing from patients who read about new treatments that could cure them of their cancer, but who are facing barriers to getting access to this care?

We do. Patients will call us, and we do have a copayment assistance foundation, we do have funding for some types of cancers. We do hear from the patients when they call us and we don’t have a fund open for their type of cancer and they are very frustrated. "My doctor says this is what I need to take and I can’t get it." Or the co-pay is $4000. Sometimes they get misinformation, too. They don’t fully understand what their out of pocket is versus what the full cost of the drug is.

We do hear from patients, "This is great, I heard this medication can save my life, but I can’t get it." We will refer them to the drug company but even that, I guess, patients have to qualify for those programs. Medicare patients are not usually eligible for manufacturer sponsored programs. So, it does leave a lot of gaps in coverage for a lot of people.

Related Videos
Screenshot of Susan Wescott, RPh, MBA
Screenshot of an interview with Adam Colborn, JD
Screenshot of an interview with James Chambers, PhD
Screenshot of an interview with Megan Ehret, PharmD
Interview screenshot with Megan Ehret, PharmD
Screenshot of an interview with Susan Wescott, RPh, MBA
Screenshot of an interview with Nadine Barrett, PhD
Female doctor in coat with stethoscope on blue background - Pixel-Shot - stock.adobe.com
Anna-Maria Hoffmann-Vold, MD, PhD, a senior consultant and leader of inflammatory and fibrotic research area at Oslo University Hospital
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.